The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of the combination of alisertib (Aurora A kinase inhibitor) and MLN0128 (dual TORC1/2 Inhibitor) in patients with advanced solid tumors, final expansion cohort data.
 
S. Lindsey Davis
Consulting or Advisory Role - Genentech
Speakers' Bureau - Allergan (I)
Research Funding - AstraZeneca (Inst); Boston Scientific (I); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Halozyme (Inst); I-Mab (Inst); Incyte (Inst); Merck (Inst); OncoMed (Inst); ORIC Pharmaceuticals (Inst); Roche (Inst); Senhwa Biosciences (Inst); Symphogen (Inst)
 
Alexis Diane Leal
Employment - Elsevier
Leadership - Elsevier
Research Funding - Abbvie (Inst); Arrys Therapeutics (Inst); Bristol-Myers Squibb (Inst); Conjupro Biotherapeutics (Inst); Corcept Therapeutics (Inst); Exelixis (Inst); Hutchison MediPharma (Inst); Takeda (Inst)
 
Wells A. Messersmith
Consulting or Advisory Role - Five Prime Therapeutics (Inst); QED Therapeutics
Research Funding - Alexo Therapeutics (Inst); Beigene (Inst); D3 (Inst); Immunomedics (Inst); OncoMed (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - HalioDx (Inst); Ipsen (Inst); Pfizer (Inst)
Research Funding - Merck (Inst)
 
Elaine T. Lam
Consulting or Advisory Role - Calithera Biosciences
Research Funding - Advaxis (Inst); Amgen (Inst); Argos Therapeutics (Inst); Arrowhead Pharmaceuticals (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); Decibel Therapeutics (Inst); Exelixis (Inst); FORMA Therapeutics (Inst); Harpoon Therapeutics (Inst); Merck (Inst); OnQuality Pharmaceuticals (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Phosplatin Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Decibel Therapeutics
 
Bradley Corr
Consulting or Advisory Role - AstraZeneca/Merck (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novocure (Inst)
Research Funding - Clovis Oncology (Inst)
 
Cindy L. O'Bryant
Honoraria - International Academic Symposium on Antineoplastic Drug; National Comprehensive Cancer Network; University Learning Systems
Consulting or Advisory Role - Eagle Pharmaceuticals; Pfizer
Research Funding - Pfizer; Tesaro
Travel, Accommodations, Expenses - Blood & Marrow Transplant Information Network; Board of Pharmacy Specialties; Pfizer; University Learning Systems
 
Natalie Julie Serkova
No Relationships to Disclose
 
Todd Pitts
Research Funding - ALX Oncology; AstraZeneca; Exelixis; Takeda
 
Jennifer Robinson Diamond
Leadership - OnKure (Inst)
Stock and Other Ownership Interests - OnKure
Consulting or Advisory Role - immunomedics
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Immunomedics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); OnKure (Inst); Rexahn Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)